Moderna’s New Flu Shot Shows Strong Results in Older Adults
TUESDAY, July 1, 2025 (HealthDay News) — Moderna’s new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major trial, the company announced Monday. The vaccine, called mRNA-1010, was tested in a Phase 3 study in adults aged 50 and older.Continue Reading